About this episode
In this episode we are joined by Suzanne Frank. We discuss Inavo120 (Inavolisib-Based Therapy in PIK3CA-Mutated Advanced Breast Cancer) study. We discuss the relevance of the data and how it might change practice going forward. This study is available to read at https://www.nejm.org/doi/full/10.1056/NEJMoa2404625 and the update at https://ascopubs.org/doi/10.1200/JCO.2024.42.16_suppl.1003
Get every episode summarized
Each time Let's Talk About SACT publishes, we email you a written briefing from the transcript — the topics, who appeared, and any specific claims, with the ad reads skipped.
Email me new episodesFree for 3 shows. No card needed.
Hosts & guests
No transcript yet
This episode has not been transcribed. Request it and it moves to the front of the queue.
More episodes
More from Let's Talk About SACT
Let's Talk About Melanoma Focus
Let's Talk About SACT
Mar 3, 202622:31completed
Let's Talk About Menopause and Cancer
Let's Talk About SACT
Jan 14, 202624:08pending
Let's Talk About The Immunotherapy Specialist Advisory Group
Let's Talk About SACT
Dec 1, 202533:19pending
Let's Talk About The Cancer Research UK Consent Form Project
Let's Talk About SACT
Nov 13, 202524:39pending